FOXP3 and neoplasm: We performed immunohistochemistry analyses using FOXP3 and CD163 antibodies in the validation cohort and found very pronounced macrophage infiltration (CD163) but hardly Treg infiltration (FOXP3) into the tumor site in some samples.